New drug cocktail targets advanced cervical cancer in 41-Patient trial
NCT ID NCT07542717
First seen Apr 29, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This study tests a combination of two drugs (MRG003 and QL1706) in 41 adults with recurrent or metastatic cervical cancer that worsened after platinum-based chemotherapy. The goal is to see how many patients' tumors shrink or disappear. Participants must have measurable tumors and be in good overall health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.